: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Chronic Heart Failure

Free Subscription

Articles published in Circulation
Retrieve available abstracts of 405 articles:
HTML format

Single Articles

March 2021

LOOMBA RS, Villarreal EG, Flores S
Letter by Loomba et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
Circulation. 2021;143:e755-e756.
PubMed

NAVARRO CASTELLANOS I, Dahdah N
Letter by Navarro Castellanos and Dahdah Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
Circulation. 2021;143:e759-e760.
PubMed

CARDENAS SURI H, Jimomila Bening D
Letter by Cardenas Suri and Jimomila Bening Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
Circulation. 2021;143:e757-e758.
PubMed

REN C, Qian M, Han C
Letter by Ren et al Regarding Article, "Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic".
Circulation. 2021;143:e761-e762.
PubMed

YU H, Zhang F, Yan P, Zhang S, et al
LARP7 Protects Against Heart Failure by Enhancing Mitochondrial Biogenesis.
Circulation. 2021 Mar 5. doi: 10.1161/CIRCULATIONAHA.120.050812.
PubMed Abstract available

February 2021

UMAPATHI P, Banerjee PS, Zachara NE, Abrol N, et al
Excessive O - GlcNAcylation Causes Heart Failure and Sudden Death.
Circulation. 2021 Feb 17. doi: 10.1161/CIRCULATIONAHA.120.051911.
PubMed Abstract available

PACKER DL, Piccini JP, Monahan KH, Al-Khalidi HR, et al
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results from the CABANA Trial.
Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.050991.
PubMed Abstract available

NASSIF ME, Qintar M, Windsor SL, Jermyn R, et al
Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial.
Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.052503.
PubMed Abstract available

January 2021

Correction to: Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from EMPEROR-Reduced.
Circulation. 2021;143:e29.
PubMed

Correction to: Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Circulation. 2021;143:e30.
PubMed

KOSIBOROD M
Diamonds in the Rough: The Incredible-but-True Story of Sodium Glucose Cotransporter 2 Inhibitors in Treatment of Heart Failure.
Circulation. 2021;143:350-353.
PubMed

CARNICELLI AP, Mentz RJ
Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: The Heart and Kidney Working Better Together.
Circulation. 2021;143:322-325.
PubMed

HANG PZ, Zhao J
Letter by Hang and Zhao Regarding Article, "Cardiac Overexpression of PDE4B Blunts beta-Adrenergic Response and Maladaptive Remodeling in Heart Failure".
Circulation. 2021;143:e24-e25.
PubMed

VANDECASTEELE G, Mika D, Margaria JP, Ghigo A, et al
Response by Vandecasteele et al to Letter Regarding Article, "Cardiac Overexpression of PDE4B Blunts beta-Adrenergic Response and Maladaptive Remodeling in Heart Failure".
Circulation. 2021;143:e26-e27.
PubMed

BACKHAUS SJ, Lange T, George EF, Hellenkamp K, et al
Exercise-Stress Real-time Cardiac Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: The HFpEF Stress Trial.
Circulation. 2021 Jan 21. doi: 10.1161/CIRCULATIONAHA.120.051542.
PubMed Abstract available

CHURCHILL TW, Li SX, Curreri L, Zern EK, et al
Evaluation of 2 Existing Diagnostic Scores for Heart Failure With Preserved Ejection Fraction Against a Comprehensively Phenotyped Cohort.
Circulation. 2021;143:289-291.
PubMed

December 2020

MCMURRAY JJV, Packer M
How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction? A Redefinition of Evidence-Based Medicine.
Circulation. 2020 Dec 30. doi: 10.1161/CIRCULATIONAHA.120.052926.
PubMed

ZANNAD F, Cowie MR
VERTIS-CV: More Evidence That Sodium Glucose Cotransporter 2 Inhibition Brings Rapid and Sustained Heart Failure Benefit.
Circulation. 2020;142:2216-2218.
PubMed

November 2020

EZEKOWITZ JA, Savu A, Welsh RC, McAlister FA, et al
Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?
Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.048015.
PubMed

SARMA S, Howden E, Lawley J, Samels M, et al
Central Command and the Regulation of Exercise Heart Rate Response in Heart Failure with Preserved Ejection Fraction.
Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.048338.
PubMed Abstract available

ALLEN LA, Venechuk G, McIlvennan CK, Page Ii RL, et al
An Electronically Delivered, Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure with Reduced Ejection Fraction: The EPIC-HF Trial.
Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051863.
PubMed Abstract available

Correction to: Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Circulation. 2020;142:e369.
PubMed

LI X, Xue Q, Wang M, Zhou T, et al
Adherence to a Healthy Sleep Pattern and Incident Heart Failure: A Prospective Study of 408802 UK Biobank Participants.
Circulation. 2020 Nov 16. doi: 10.1161/CIRCULATIONAHA.120.050792.
PubMed

LEE MMY, Brooksbank KJM, Wetherall K, Mangion K, et al
Effect of Empagliflozin on Left Ventricular Volumes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF).
Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.052186.
PubMed Abstract available

ANKER SD, Butler J, Filippatos G, Khan MS, et al
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial.
Circulation. 2020 Nov 11. doi: 10.1161/CIRCULATIONAHA.120.051824.
PubMed Abstract available

GIERULA J, Lowry JE, Paton MF, Cole CA, et al
Response by Gierula et al to Letter Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study".
Circulation. 2020;142:e319-e320.
PubMed

LAU CP, Tse HF
Letter by Lau and Tse Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study".
Circulation. 2020;142:e317-e318.
PubMed

ALBERT CL, Carmona-Rubio AE, Weiss AJ, Procop GG, et al
The Enemy Within: Sudden-Onset Reversible Cardiogenic Shock With Biopsy-Proven Cardiac Myocyte Infection by Severe Acute Respiratory Syndrome Coronavirus 2.
Circulation. 2020;142:1865-1870.
PubMed

PATEL KV, Bahnson JL, Gaussoin SA, Johnson KC, et al
Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050941.
PubMed

Correction to: Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
Circulation. 2020;142:e316.
PubMed

HO JE, Redfield MM, Lewis GD, Paulus WJ, et al
Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction.
Circulation. 2020;142:1770-1780.
PubMed Abstract available

October 2020

HAHN VS, Knutsdottir H, Luo X, Bedi K, et al
Myocardial Gene Expression Signatures in Human Heart Failure with Preserved Ejection Fraction.
Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050498.
PubMed Abstract available

BIRKS EJ, Drakos SG, Patel SR, Lowes BD, et al
A Prospective Multicentre Study of Myocardial Recovery Using Left Ventricular Assist Devices (REmission from Stage D Heart Failure: RESTAGE-HF): Medium Term and Primary Endpoint Results.
Circulation. 2020 Oct 26. doi: 10.1161/CIRCULATIONAHA.120.046415.
PubMed Abstract available

ZANNAD F, Ferreira JP, Pocock SJ, Zeller C, et al
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Reduced Trial.
Circulation. 2020 Oct 23. doi: 10.1161/CIRCULATIONAHA.120.051685.
PubMed Abstract available

PACKER M, Anker SD, Butler J, Filippatos GS, et al
Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Circulation. 2020 Oct 21. doi: 10.1161/CIRCULATIONAHA.120.051783.
PubMed Abstract available

THIBODEAU JT, Gorodeski EZ
Telehealth for Uptitration of Guideline-Directed Medical Therapy in Heart Failure.
Circulation. 2020;142:1507-1509.
PubMed

Correction to: Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
Circulation. 2020;142:e234.
PubMed

Correction to: Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
Circulation. 2020;142:e236.
PubMed

JHUND PS, Solomon SD, Docherty KF, Heerspink HJL, et al
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF.
Circulation. 2020 Oct 12. doi: 10.1161/CIRCULATIONAHA.120.050391.
PubMed Abstract available

SANDERS-VAN WIJK S, Tromp J, Beussink-Nelson L, Hage C, et al
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure with Preserved Ejection Fraction: Results from the PROMIS-HFpEF Study.
Circulation. 2020 Oct 9. doi: 10.1161/CIRCULATIONAHA.120.045810.
PubMed Abstract available

COSENTINO F, Cannon CP, Cherney DZI, Masiukiewicz U, et al
Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.
Circulation. 2020 Oct 7. doi: 10.1161/CIRCULATIONAHA.120.050255.
PubMed Abstract available

September 2020

TOBE SW, Poon S
Angiotensin Receptor-Neprilysin Inhibitor Therapy for Heart Failure With Preserved Ejection Fraction Improves Renal Outcomes.
Circulation. 2020;142:1246-1248.
PubMed

KHAN MS, Fonarow GC, McGuire DK, Hernandez AF, et al
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization.
Circulation. 2020;142:1205-1218.
PubMed Abstract available

LI J, Tan Y, Passariello CL, Martinez EC, et al
Signalosome-Regulated SRF Phosphorylation Determining Myocyte Growth in Width versus Length as a Therapeutic Target for Heart Failure.
Circulation. 2020 Sep 16. doi: 10.1161/CIRCULATIONAHA.119.044805.
PubMed Abstract available

GRODIN JL, Tang WHW
Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney.
Circulation. 2020;142:1055-1058.
PubMed

PARCHA V, Patel N, Kalra R, Arora G, et al
Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial.
Circulation. 2020;142:1018-1020.
PubMed

VERBRUGGE FH, Guazzi M, Testani JM, Borlaug BA, et al
Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney.
Circulation. 2020;142:998-1012.
PubMed Abstract available

CHAN MY, Efthymios M, Tan SH, Pickering JW, et al
Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
Circulation. 2020 Sep 4. doi: 10.1161/CIRCULATIONAHA.119.045158.
PubMed Abstract available

DOCHERTY KF, Jhund PS, Anand I, Bengtsson O, et al
Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.
Circulation. 2020 Sep 4. doi: 10.1161/CIRCULATIONAHA.120.047480.
PubMed Abstract available

DURSTENFELD MS, Hsue PY
An Unusual, Reversible Cause of Acute High-Output Heart Failure Complicated by Refractory Shock.
Circulation. 2020;142:901-905.
PubMed

August 2020

MORDI NA, Mordi IR, Singh JS, McCrimmon RJ, et al
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.048739.
PubMed Abstract available

LOPES RD, Alexander KP, Stevens SR, Reynolds HR, et al
Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050304.
PubMed Abstract available

MC CAUSLAND FR, Lefkowitz MP, Claggett B, Anavekar NS, et al
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure with Preserved Ejection Fraction.
Circulation. 2020 Aug 17. doi: 10.1161/CIRCULATIONAHA.120.047643.
PubMed Abstract available

CHEN F, Chen ZQ, Zhu JJ
Letter by Chen et al Regarding Article, "Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study".
Circulation. 2020;142:e67-e68.
PubMed

LEWIS AA, de Lemos JA
Response by Lewis and de Lemos to Letter Regarding Article, "Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study".
Circulation. 2020;142:e69-e70.
PubMed

SIMPSON JM, Newburger JW
Multisystem Inflammatory Syndrome in Children in Association With COVID-19.
Circulation. 2020;142:437-440.
PubMed

July 2020

JACKSON AM, Dewan P, Anand IS, Belohlavek J, et al
Dapagliflozin and Diuretic Use in Patients with Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Circulation. 2020 Jul 16. doi: 10.1161/CIRCULATIONAHA.120.047077.
PubMed Abstract available

JACKSON AM, Jhund PS, Solomon SD, McMurray JJV, et al
Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF".
Circulation. 2020;142:e5-e6.
PubMed

WU K, Zhao S
Letter by Wu and Zhao Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF".
Circulation. 2020;142:e3-e4.
PubMed

June 2020

AL-KHATIB SM, Benjamin EJ, Albert CM, Alonso A, et al
Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop.
Circulation. 2020;141:1915-1926.
PubMed Abstract available

PANDEY A, Vaduganathan M, Arora S, Qamar A, et al
Temporal Trends in Prevalence & Prognostic Implications of Comorbidities Among Patients with Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.
Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047019.
PubMed Abstract available

HONG YS, Longchamps RJ, Zhao D, Castellani CA, et al
Mitochondrial DNA Copy Number and Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study.
Circulation. 2020;141:1823-1825.
PubMed

SELVARAJ S, Kelly DP, Margulies KB
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
Circulation. 2020;141:1800-1812.
PubMed Abstract available

May 2020

SARMA S, Levine BD
Response by Sarma and Levine to Letter Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
Circulation. 2020;141:e822.
PubMed

KOMAMURA K
Letter by Komamura Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
Circulation. 2020;141:e819.
PubMed

BELKIN M, Michou E, Mueller C
Letter by Belkin et al Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
Circulation. 2020;141:e820-e821.
PubMed

NWABUO CC, Rana JS
Letter by Nwabuo and Rana Regarding Article, "Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction".
Circulation. 2020;141:e817-e818.
PubMed

BELHADJER Z, Meot M, Bajolle F, Khraiche D, et al
Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic.
Circulation. 2020 May 17. doi: 10.1161/CIRCULATIONAHA.120.048360.
PubMed Abstract available

GRIFFIN M, Rao VS, Ivey-Miranda J, Fleming J, et al
Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects.
Circulation. 2020 May 15. doi: 10.1161/CIRCULATIONAHA.120.045691.
PubMed Abstract available

Correction to: Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations.
Circulation. 2020;141:e809.
PubMed

April 2020

BADOLIA R, Ramadurai DKA, Abel ED, Ferrin P, et al
The Role of Non-Glycolytic Glucose Metabolism in Myocardial Recovery upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.
Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.119.044452.
PubMed Abstract available

KITKO L, McIlvennan CK, Bidwell JT, Dionne-Odom JN, et al
Family Caregiving for Individuals With Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2020 Apr 30:CIR0000000000000768. doi: 10.1161/CIR.0000000000000768.
PubMed Abstract available

WHITE-WILLIAMS C, Rossi LP, Bittner VA, Driscoll A, et al
Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2020 Apr 30:CIR0000000000000767. doi: 10.1161/CIR.0000000000000767.
PubMed Abstract available

ARMSTRONG PW
Enhancing Cardiovascular Care: Global Collaboration Is How It Happens.
Circulation. 2020;141:1357-1359.
PubMed

GIERULA J, Lowry JE, Paton MF, Cole CA, et al
Personalised Rate-Response Programming Improves Exercise Tolerance After Six Months in People with Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
Circulation. 2020 Apr 17. doi: 10.1161/CIRCULATIONAHA.119.045066.
PubMed Abstract available

KARAM S, Margaria JP, Bourcier A, Mika D, et al
Cardiac Overexpression of PDE4B Blunts beta-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Circulation. 2020 Apr 8. doi: 10.1161/CIRCULATIONAHA.119.042573.
PubMed Abstract available

FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
The Variety of Cardiovascular Presentations of COVID-19.
Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
PubMed

CHIRINOS JA, Zhao L, Jia Y, Frej C, et al
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure.
Circulation. 2020 Apr 2. doi: 10.1161/CIRCULATIONAHA.119.045323.
PubMed Abstract available

March 2020

TOTO RD
Leveraging the Peritoneum as a New Diuretic Strategy for Heart Failure.
Circulation. 2020;141:1054-1056.
PubMed

SHAH SJ, Borlaug BA, Kitzman DW, McCulloch AD, et al
Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.
Circulation. 2020;141:1001-1026.
PubMed Abstract available

LITTMANN L
Letter by Littmann Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure R
Circulation. 2020;141:e646-e647.
PubMed

SCHRAGE B, Linde C, Braunschweig F, Savarese G, et al
Response by Schrage et al to Letter Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedis
Circulation. 2020;141:e648-e649.
PubMed

CHARTON M, Flecher E, Leclercq C, Delmas C, et al
Suicide Attempts Among LVAD Recipients: Real-Life Data From the ASSIST-ICD Study.
Circulation. 2020;141:934-936.
PubMed

CAPORIZZO MA, Chen CY, Bedi K, Margulies KB, et al
Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium.
Circulation. 2020;141:902-915.
PubMed Abstract available

PANDEY A, Patel KV, Bahnson JL, Gaussoin SA, et al
Association of Intensive Lifestyle Intervention, Fitness and Body Mass Index with Risk of Heart Failure in Overweight or Obese Adults with Type 2 Diabetes Mellitus: An Analysis from the Look AHEAD Trial.
Circulation. 2020 Mar 5. doi: 10.1161/CIRCULATIONAHA.119.044865.
PubMed Abstract available

SCHIATTARELLA GG, Tong D, Hill JA
Can HFpEF and HFrEF Coexist?
Circulation. 2020;141:709-711.
PubMed

February 2020

KUEHN BM
Race May Influence Transplant Decision Making in Heart Failure: Studies Also Detail Disparities in Hypertension Diagnosis, Statin Prescribing.
Circulation. 2020;141:694-695.
PubMed

ROSENKRANZ S, Howard LS, Gomberg-Maitland M, Hoeper MM, et al
Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.
Circulation. 2020;141:678-693.
PubMed Abstract available

OMIYA S, Omori Y, Taneike M, Murakawa T, et al
Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts.
Circulation. 2020;141:667-677.
PubMed Abstract available

HILFIKER-KLEINER D, Konig T, Bauersachs J
Natriuretic Peptide Receptor 1, a Novel Player in Peripartum Heart Failure.
Circulation. 2020;141:589-591.
PubMed

KHOSROW-KHAVAR F, Filion KB, Bouganim N, Suissa S, et al
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
Circulation. 2020;141:549-559.
PubMed Abstract available

KUEHN BM
Biomarkers May Help Stratify Patient Heart Failure Risk, Guide Treatment.
Circulation. 2020;141:399-400.
PubMed

BOZKURT B, Ezekowitz J
Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials.
Circulation. 2020;141:362-366.
PubMed

January 2020

BERGMARK BA, Bhatt DL, McGuire DK, Scirica BM, et al
Response by Bergmark et al to Letter Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial".
Circulation. 2020;141:e57-e58.
PubMed

MORDI IR, Mohan M, Lang CC
Letter by Mordi et al Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial".
Circulation. 2020;141:e55-e56.
PubMed

GOMES CPDC, Schroen B, Kuster GM, Robinson EL, et al
Regulatory RNAs in Heart Failure.
Circulation. 2020;141:313-328.
PubMed Abstract available

LEWIS AA, Ayers CR, Selvin E, Neeland I, et al
Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multi-Cohort Study.
Circulation. 2020 Jan 14. doi: 10.1161/CIRCULATIONAHA.119.043628.
PubMed Abstract available

HIEDA M, Sarma S, Hearon CM Jr, Dias KA, et al
Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.
Circulation. 2020;141:115-123.
PubMed Abstract available

PATERSON DI, Wells G, Erthal F, Mielniczuk L, et al
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients with Non-Ischemic Heart Failure (IMAGE-HF 1B).
Circulation. 2020 Jan 8. doi: 10.1161/CIRCULATIONAHA.119.043964.
PubMed Abstract available

PACKER M, Lam CSP, Lund LH, Redfield MM, et al
Interdependence of Atrial Fibrillation and Heart Failure With a Preserved Ejection Fraction Reflects a Common Underlying Atrial and Ventricular Myopathy.
Circulation. 2020;141:4-6.
PubMed

FAYSSOIL A
Letter by Fayssoil Regarding Article, "Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction".
Circulation. 2020;141:e1-e2.
PubMed

December 2019

BUTLER J, Packer M, Greene SJ, Fiuzat M, et al
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
Circulation. 2019;140:2108-2118.
PubMed Abstract available

November 2019

TONG D, Schiattarella GG, Jiang N, May HI, et al
Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.
Circulation. 2019;140:1769-1771.
PubMed

SOLOMON SD, Vaduganathan M, Claggett BL, Packer M, et al
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044586.
PubMed Abstract available

MCMURRAY JJV, Jackson AM, Lam CSP, Redfield MM, et al
Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF.
Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044491.
PubMed Abstract available

KOSIBOROD MN, Jhund P, Docherty KF, Diez M, et al
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial.
Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044138.
PubMed Abstract available

FELKER GM
Building the Foundation for a New Era of Quadruple Therapy in Heart Failure.
Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044578.
PubMed Abstract available

MARTINEZ FA, Serenelli M, Nicolau JC, Petrie MC, et al
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF.
Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044133.
PubMed

DEHARO P, Bisson A, Herbert J, Lacour T, et al
Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis: Data from a Nationwide Analysis.
Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043971.
PubMed Abstract available

ARNOTT C, Neal B
Do GLP-1 Receptor Agonists Care if You Have Heart Failure?
Circulation. 2019;140:1623-1625.
PubMed

JIA X, Sun W, Hoogeveen RC, Nambi V, et al
Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
Circulation. 2019;140:e772-e773.
PubMed

LI D, Cheng Y
Letter by Li and Cheng Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
Circulation. 2019;140:e770-e771.
PubMed

DJOUSSE L, Cook NR, Kim E, Bodar V, et al
Supplementation with Vitamin D and/or Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure.
Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044645.
PubMed Abstract available

October 2019

MARTINI E, Kunderfranco P, Peano C, Carullo P, et al
Single Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation.
Circulation. 2019 Oct 30. doi: 10.1161/CIRCULATIONAHA.119.041694.
PubMed Abstract available

ELGHAZALY H, Hajiev S, Singh P
Letter by Elghazaly et al Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus".
Circulation. 2019;140:e738-e739.
PubMed

KATO ET, Sabatine MS, Wiviott SD
Response by Kato et al to Letter Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus".
Circulation. 2019;140:e740-e741.
PubMed

DRAZNER MH, Stevenson LW
Relief and Prevention of Congestion in Heart Failure Enhance Quality and Length of Life.
Circulation. 2019;140:1380-1382.
PubMed

TROMP J, Hage C, Ouwerkerk W, Sanders-van Wijk S, et al
Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
Circulation. 2019;140:1359-1361.
PubMed

KUEHN BM
Gut Microbes Role in Heart Failure Explored.
Circulation. 2019;140:1217-1218.
PubMed

TIAN R, Colucci WS, Arany Z, Bachschmid MM, et al
Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure-A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
Circulation. 2019;140:1205-1216.
PubMed Abstract available

September 2019

BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
PubMed Abstract available

BONOW RO, Mark DB, O'Gara PT
Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation.
Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043408.
PubMed

AUNG N, Vargas JD, Yang C, Cabrera CP, et al
Genome-Wide Analysis of Left Ventricular Image-Derived Phenotypes Identifies Fourteen Loci Associated with Cardiac Morphogenesis and Heart Failure Development.
Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.041161.
PubMed Abstract available

FUDIM M, White J, Pagidipati NJ, Lokhnygina Y, et al
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
Circulation. 2019 Sep 23. doi: 10.1161/CIRCULATIONAHA.119.041659.
PubMed Abstract available

KHAZANIE P, Drazner MH
The Blurred Line between Gaming and Patient Advocacy: Heart Transplant Listing Decisions in the Modern Era.
Circulation. 2019 Sep 18. doi: 10.1161/CIRCULATIONAHA.119.043034.
PubMed

Correction to: Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
Circulation. 2019;140:e692.
PubMed

NASSIF ME, Windsor S, Tang F, Khariton Y, et al
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Circulation. 2019 Sep 16. doi: 10.1161/CIRCULATIONAHA.119.042929.
PubMed

SELVARAJ S, Claggett B, Pozzi A, McMurray JJV, et al
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients with Heart Failure and Reduced Ejection Fraction:PARADIGM-HF.
Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.039920.
PubMed Abstract available

SCHRAGE B, Uijl A, Benson L, Westermann D, et al
Association Between Use of Primary Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients with Heart Failure: A Prospective Propensity-Score Matched Analysis from the Swedish Heart Failure Registry.
Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043012.
PubMed Abstract available

AL-KHATIB SM, Kusumoto FM
Implantable Cardioverter Defibrillators Have Stood the Test of Time!
Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043354.
PubMed

August 2019

BERG DD, Wiviott SD, Scirica BM, Gurmu Y, et al
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
Circulation. 2019 Aug 31. doi: 10.1161/CIRCULATIONAHA.119.042685.
PubMed

GRACIA E, Hamid A, Butler J
Timely Management of New-Onset Heart Failure.
Circulation. 2019;140:621-623.
PubMed

CLELAND JGF, Pellicori P
Myocardial Dysfunction and Coronary Artery Disease as Therapeutic Targets in Heart Failure.
Circulation. 2019;140:538-541.
PubMed

PACKER M
Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
Circulation. 2019;140:443-445.
PubMed

July 2019

BERGMARK BA, Bhatt DL, McGuire DK, Cahn A, et al
Metformin Use and Clinical Outcomes among Patients with Diabetes with or without Heart Failure or Kidney Dysfunction: Observations from the SAVOR-TIMI 53 Trial.
Circulation. 2019 Jul 31. doi: 10.1161/CIRCULATIONAHA.119.040144.
PubMed Abstract available

SENNI M, Caravita S, Paulus WJ
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction?
Circulation. 2019;140:366-369.
PubMed

FAN Q, Mao H, Angelini A, Coarfa C, et al
Depletion of Endothelial Prolyl Hydroxylase Domain Protein 2 and 3 Promotes Cardiomyocyte Proliferation and Prevents Ventricular Failure Induced by Myocardial Infarction.
Circulation. 2019;140:440-442.
PubMed

FELDMAN AM, Gerhard GS, Cheung JY
Letter by Feldman et al Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery".
Circulation. 2019;140:e5-e6.
PubMed

ARAGAM KG, Chaffin M, Ellinor PT, Kathiresan S, et al
Response by Aragam et al to Letter Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery".
Circulation. 2019;140:e7-e8.
PubMed

June 2019

VERMA S, Lam CSP, Kosiborod M
Empagliflozin and Heart Failure.
Circulation. 2019;139:2831-2834.
PubMed

KRONLAGE M, Dewenter M, Grosso J, Fleming T, et al
O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart from Failure.
Circulation. 2019 Jun 14. doi: 10.1161/CIRCULATIONAHA.117.031942.
PubMed Abstract available

GOLDENBERG JR, Carley AN, Ji R, Zhang X, et al
Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Circulation. 2019;139:2765-2777.
PubMed Abstract available

DUNLAY SM, Givertz MM, Aguilar D, Allen LA, et al
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
Circulation. 2019 Jun 6:CIR0000000000000691. doi: 10.1161/CIR.0000000000000691.
PubMed Abstract available

BRANCH KR, Probstfield JL, Eikelboom JW, Bosch J, et al
Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609.
PubMed Abstract available

May 2019

BENFARI G, Antoine C, Miller WL, Thapa P, et al
Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction.
Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038946.
PubMed Abstract available

VAN DER MEER P, van der Wal HH, Melenovsky V
Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart Failure.
Circulation. 2019;139:2399-2402.
PubMed

TESTANI JM, Inzucchi SE, Voors AA
Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time?
Circulation. 2019;139:2383-2385.
PubMed

SEPEHRVAND N, Alemayehu W, Dyck GJB, Dyck JRB, et al
External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.
Circulation. 2019;139:2377-2379.
PubMed

NYSTROM T, Sartipy U, Contardi A, Lind M, et al
Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction.
Circulation. 2019;139:2380-2382.
PubMed

SMITH GL, Eisner DA
Calcium Buffering in the Heart in Health and Disease.
Circulation. 2019;139:2358-2371.
PubMed Abstract available

ENRIQUEZ-SARANO M, Michelena HI, Grigioni F
Treatment of Functional Mitral Regurgitation.
Circulation. 2019;139:2289-2291.
PubMed

GOPINATHANNAIR R, Cornwell WK, Dukes JW, Ellis CR, et al
Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.
Circulation. 2019;139:e967-e989.
PubMed Abstract available

PACKER M, Grayburn PA
Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
Circulation. 2019 May 1. doi: 10.1161/CIRCULATIONAHA.119.039612.
PubMed Abstract available

April 2019

JIA X, Sun W, Hoogeveen RC, Nambi V, et al
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
Circulation. 2019 Apr 29. doi: 10.1161/CIRCULATIONAHA.118.038772.
PubMed Abstract available

SANO M, Goto S
Possible Mechanism of Hematocrit Elevation by Sodium Glucose Cotransporter 2 Inhibitors and Associated Beneficial Renal and Cardiovascular Effects.
Circulation. 2019;139:1985-1987.
PubMed

RANGASWAMI J, Bhalla V, Blair JEA, Chang TI, et al
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
Circulation. 2019;139:e840-e878.
PubMed Abstract available

SEGAR MW, Patel KV, Berry JD, Grodin JL, et al
Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction.
Circulation. 2019;139:1851-1853.
PubMed

MORROW DA, Velazquez EJ, DeVore AD, Desai AS, et al
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.
Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.039331.
PubMed

PATORNO E, Pawar A, Franklin JM, Najafzadeh M, et al
Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care: A First Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.
Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.039177.
PubMed Abstract available

March 2019

NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
PubMed Abstract available

BOTS SH, den Ruijter HM
Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
Circulation. 2019;139:1469-1471.
PubMed

KATO ET, Silverman MG, Mosenzon O, Zelniker TA, et al
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040130.
PubMed Abstract available

VERMA S, McMurray JJV
The Serendipitous Story of SGLT2 Inhibitors in Heart Failure: New Insights from DECLARE-TIMI 58.
Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040514.
PubMed Abstract available

FURTADO RHM, Bonaca MP, Raz I, Zelniker TA, et al
Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial.
Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039996.
PubMed Abstract available

JUKEMA JW, Timal RJ, Rotmans JI, Hensen LCR, et al
Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients: The Prospective Randomized Controlled ICD2 Trial.
Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039818.
PubMed Abstract available

FIGTREE GA, Radholm K, Barrett TD, Perkovic V, et al
Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program.
Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040057.
PubMed Abstract available

KUMAR AA, Kelly DP, Chirinos JA
Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Circulation. 2019;139:1435-1450.
PubMed Abstract available

SAVARESE G, Sattar N, Januzzi J, Verma S, et al
Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.
Circulation. 2019;139:1458-1460.
PubMed

February 2019

SAHA P, Potiny P, Rigdon J, Morello M, et al
Substantial Cardiovascular Morbidity in Adults with Lower-Complexity Congenital Heart Disease.
Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.037064.
PubMed Abstract available

COLLINS SP, Pang PS
ACUTE Heart Failure Risk Stratification.
Circulation. 2019;139:1157-1161.
PubMed

RAWSHANI A, Rawshani A, Sattar N, Franzen S, et al
Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes.
Circulation. 2019 Feb 25. doi: 10.1161/CIRCULATIONAHA.118.037454.
PubMed Abstract available

HSICH EM
Sex Differences in Advanced Heart Failure Therapies.
Circulation. 2019;139:1080-1093.
PubMed Abstract available

CHARLES-EDWARDS G, Amaral N, Sleigh A, Ayis S, et al
Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients with Chronic Heart Failure and Iron Deficiency: The FERRIC-HF II Randomized Mechanistic Trial.
Circulation. 2019 Feb 19. doi: 10.1161/CIRCULATIONAHA.118.038516.
PubMed Abstract available

DEL BUONO MG, Carbone S, Abbate A
Letter by Del Buono et al Regarding Article, "A Simple, Evidence-Based Approach To Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
Circulation. 2019;139:990-991.
PubMed

COBOS GIL MA
Letter by Cobos Gil Regarding Article, "A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
Circulation. 2019;139:989.
PubMed

REDDY YNV, Borlaug BA
Response by Reddy and Borlaug to Letters Regarding Article, "A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
Circulation. 2019;139:992-993.
PubMed

MORDI IR, Pearson ER, Palmer CNA, Doney ASF, et al
Differential Association of Genetic Risk of Coronary Artery Disease With Development of Heart Failure With Reduced Versus Preserved Ejection Fraction.
Circulation. 2019;139:986-988.
PubMed

LEE DP, Tan WLW, Anene-Nzelu CG, Lee CJM, et al
A Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene Response.
Circulation. 2019 Feb 5. doi: 10.1161/CIRCULATIONAHA.118.036726.
PubMed Abstract available

January 2019

CHEN Y, Nilsson J, Liang C
Letter by Chen et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
Circulation. 2019;139:716-717.
PubMed

MEIJERS WC, de Boer RA
Response by Meijers and de Boer to Letters Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
Circulation. 2019;139:720-721.
PubMed

DEVORE AD, Bhatt AS
Influenza Vaccination in Patients With Heart Failure.
Circulation. 2019;139:587-589.
PubMed

ZHANG J, Lan HY, Wan S
Letter by Zhang et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
Circulation. 2019;139:718-719.
PubMed

MATHIYALAGAN P, Adamiak M, Mayourian J, Sassi Y, et al
FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.
Circulation. 2019;139:518-532.
PubMed Abstract available

FIGTREE GA, Radholm K, Neal B
Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
Circulation. 2019;139:418-419.
PubMed

KOH KK
Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
Circulation. 2019;139:416-417.
PubMed

ZANNAD F, Rossignol P
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure.
Circulation. 2019;139:362-365.
PubMed

ZHOU L, Li Z, Wang DW
Response by Zhou et al to Letter Regarding Article, "Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure".
Circulation. 2019;139:301-302.
PubMed

GREENE SJ, Butler J
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.
Circulation. 2019;139:152-154.
PubMed

FRANGOGIANNIS NG
Protean Functions and Phenotypic Plasticity of Regulatory T Cells in Chronic Ischemic Heart Failure.
Circulation. 2019;139:222-225.
PubMed

MORIS D, Karachaliou GS, Karaolanis G
Letter by Moris et al Regarding Article, "Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure".
Circulation. 2019;139:299-300.
PubMed

ANDERSEN S, Nielsen-Kudsk JE, Vonk Noordegraaf A, de Man FS, et al
Right Ventricular Fibrosis.
Circulation. 2019;139:269-285.
PubMed Abstract available

December 2018

ANAND I, Gupta P
Response by Anand and Gupta to Letter Regarding Article, "Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies".
Circulation. 2018;138:2976-2977.
PubMed

DE LAS NIEVES LOPEZ MA
Letter by de las Nieves Lopez Regarding Article, "Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies".
Circulation. 2018;138:2974-2975.
PubMed

TROMP J, MacDonald MR, Tay WT, Teng TK, et al
Heart Failure With Preserved Ejection Fraction in the Young.
Circulation. 2018;138:2763-2773.
PubMed Abstract available

AMBROSY AP, Parzynski CS, Friedman DJ, Fudim M, et al
Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
Circulation. 2018;138:2787-2797.
PubMed Abstract available

JERNBERG T, Lindahl B, Alfredsson J, Berglund E, et al
Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
Circulation. 2018;138:2754-2762.
PubMed Abstract available

MODIN D, Jorgensen ME, Gislason G, Jensen JS, et al
Influenza Vaccine in Heart Failure: Cumulative Number of Vaccinations, Frequency, Timing, and Survival: A Danish Nationwide Cohort Study.
Circulation. 2018 Dec 10. doi: 10.1161/CIRCULATIONAHA.118.036788.
PubMed Abstract available

FITCHETT D, Inzucchi SE, Cannon CP, McGuire DK, et al
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
Circulation. 2018 Dec 6. doi: 10.1161/CIRCULATIONAHA.118.037778.
PubMed Abstract available

KANG DH, Park SJ, Shin SH, Hong GR, et al
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study.
Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.037077.
PubMed Abstract available

DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
Circulation. 2018;138:2597-2607.
PubMed Abstract available

November 2018

LEE DS, Lee JS, Schull MJ, Borgundvaag B, et al
Prospective Validation of the Emergency Heart Failure Mortality Risk Grad for Acute Heart Failure: The Acute Congestive Heart Failure Urgent Care Evaluation (ACUTE) Study.
Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.035509.
PubMed Abstract available

SHAH R, Latham SB
Letter by Shah and Latham Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With the Guidelines-Heart Failure".
Circulation. 2018;138:2303-2304.
PubMed

REISMAN L
Letter by Reisman Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
Circulation. 2018;138:2301-2302.
PubMed

MAHLA RS
Letter by Mahla Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
Circulation. 2018;138:2305.
PubMed

KUMBHANI DJ, Fonarow GC, Heidenreich PA, Schulte PJ, et al
Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
Circulation. 2018;138:2306-2307.
PubMed

THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
Fourth Universal Definition of Myocardial Infarction (2018).
Circulation. 2018;138:e618-e651.
PubMed

EVERETT BM, Cornel J, Lainscak M, Anker SD, et al
Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure.
Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038010.
PubMed Abstract available

MCGUIRE DK, Alexander JH, Johansen OE, Perkovic V, et al
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038352.
PubMed Abstract available

ARAGAM KG, Chaffin M, Levinson RT, McDermott G, et al
Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery.
Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035774.
PubMed Abstract available

October 2018

MATSUMOTO J, Takada S, Kinugawa S, Furihata T, et al
Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.
Circulation. 2018;138:2064-2066.
PubMed

LEROY J, Fischmeister R
Inhibit a Phosphodiesterase to Treat Heart Failure?
Circulation. 2018;138:2003-2006.
PubMed

KOK W, Stienen S
Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Adm
Circulation. 2018;138:1910-1911.
PubMed

MADIAS JE
Letter by Madias Regarding Article, "NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Deco
Circulation. 2018;138:1908-1909.
PubMed

MONTERO D
Letter by Montero Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
Circulation. 2018;138:1757-1758.
PubMed

CALVERLEY TA, Bailey DM
Letter by Calverley and Bailey Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
Circulation. 2018;138:1755-1756.
PubMed

HOWDEN EJ, Levine BD
Response by Howden and Levine to Letters Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
Circulation. 2018;138:1759-1760.
PubMed

ALOIA E
Letter by Aloia Regarding Article, "Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality".
Circulation. 2018;138:1612.
PubMed

NUNEZ J, Nunez E, Sanchis J, Bayes-Genis A, et al
Response by Nunez et al to Letter Regarding Article, "Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality".
Circulation. 2018;138:1613-1614.
PubMed

September 2018

DAWSON J
Pioglitazone Use After Stroke.
Circulation. 2018;138:1221-1223.
PubMed

COLOMBO PC, Mehra MR, Goldstein DJ, Estep JD, et al
Comprehensive Analysis of Stroke in the LongTerm Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump.
Circulation. 2018 Sep 17. doi: 10.1161/CIRCULATIONAHA.118.037231.
PubMed Abstract available

GREENE SJ, Mentz RJ, Fiuzat M, Butler J, et al
Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure.
Circulation. 2018;138:1039-1053.
PubMed Abstract available

August 2018

BERTERO E, Canepa M, Maack C, Ameri P, et al
Linking Heart Failure to Cancer.
Circulation. 2018;138:735-742.
PubMed Abstract available

ALOIA E
Letter by Aloia Regarding Article, "Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Su
Circulation. 2018;138:656-657.
PubMed

SOLIMAN O, Akin S, Muslem R, Caliskan K, et al
Response by Soliman et al to Letter Regarding Article, "Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients With Mecha
Circulation. 2018;138:658-659.
PubMed

SARRIAS A, Bayes-Genis A
Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
Circulation. 2018;138:551-553.
PubMed

July 2018

BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
Circulation. 2018;138:198-205.
PubMed Abstract available

ANAND IS, Gupta P
Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies.
Circulation. 2018;138:80-98.
PubMed Abstract available

ROGER VL
Heart Failure Epidemic: It's Complicated....
Circulation. 2018;138:25-28.
PubMed

SATTAR N, McGuire DK
Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.
Circulation. 2018;138:7-9.
PubMed

June 2018

MCALLISTER DA, Read S, Kerssens J, Livingstone S, et al
Incidence of Hospitalisation for Heart Failure and Case-Fatality Among 3.25 Million People with and without Diabetes.
Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.034986.
PubMed Abstract available

YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
PubMed Abstract available

Correction to: Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
Circulation. 2018;137:e853.
PubMed

SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
PubMed Abstract available

May 2018

PACKER M, Kowey PR
Building Castles in the Sky: Catheter Ablation in Patients With Atrial Fibrillation and Chronic Heart Failure.
Circulation. 2018 May 30. pii: CIRCULATIONAHA.118.034583.
PubMed Abstract available

MEHRA MR, Salerno C, Cleveland JC, Pinney S, et al
Health Care Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: A Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure.
Circulation. 2018 May 27. pii: CIRCULATIONAHA.118.035722.
PubMed Abstract available

FUDIM M, Jones WS, Boortz-Marx RL, Ganesh A, et al
Splanchnic Nerve Block for Acute Heart Failure.
Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.035260.
PubMed Abstract available

REDDY YNV, Carter RE, Obokata M, Redfield MM, et al
A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.
Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646.
PubMed Abstract available

WALKER MA, Tian R
Raising NAD in Heart Failure: Time to Translate?
Circulation. 2018;137:2274-2277.
PubMed

ELMING MB, Signorovitch J, Kober L, Thune JJ, et al
Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
Circulation. 2018;137:2190.
PubMed

ADABAG S, Wininger M, Singh SN
Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
Circulation. 2018;137:2188-2189.
PubMed

JANUZZI JL JR, Richards AM
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study.
Circulation. 2018;137:2101-2103.
PubMed

LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".
Circulation. 2018;137:1984-1985.
PubMed

GROCOTT HP
Letter by Grocott Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".
Circulation. 2018;137:1983.
PubMed

PACKER M
Response by Packer to Letter Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchange Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
Circulation. 2018;137:1981-1982.
PubMed

GAZMURI RJ, Karmazyn M
Letter by Gazmuri and Karmazyn Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
Circulation. 2018;137:1979-1980.
PubMed

April 2018

LEOPOLD JA
Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
Circulation. 2018;137:1811-1813.
PubMed

CHIANG DY, Alsina KM, Corradini E, Fitzpatrick M, et al
Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.
Circulation. 2018 Apr 18. pii: CIRCULATIONAHA.118.034361.
PubMed Abstract available

KAMIMURA D, Cain LR, Mentz RJ, White WB, et al
Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.
Circulation. 2018 Apr 16. pii: CIRCULATIONAHA.117.031912.
PubMed Abstract available

CHEN LY, Chung MK, Allen LA, Ezekowitz M, et al
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
Circulation. 2018 Apr 16. pii: CIR.0000000000000568.
PubMed Abstract available

VALIENTE-ALANDI I, Potter SJ, Salvador AM, Schafer AE, et al
Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Circulation. 2018 Apr 13. pii: CIRCULATIONAHA.118.034609.
PubMed Abstract available

KONSTAM MA, Kiernan MS, Bernstein D, Bozkurt B, et al
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2018 Apr 12. pii: CIR.0000000000000560.
PubMed Abstract available

PACKER M
Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity.
Circulation. 2018;137:1614-1631.
PubMed Abstract available

March 2018

KUSHNIR A, Santulli G, Reiken SR, Coromilas E, et al
Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure.
Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.117.032703.
PubMed Abstract available

SWEITZER NK, Airhart S
New Therapeutic Target in Heart Failure: Achieving and Maintaining Normokalemia.
Circulation. 2018;137:1331-1333.
PubMed

ANDERSSON C, Lyass A, Lin H, Kober L, et al
Association of Genetic Variation in Coronary Artery Disease-Related Loci With the Risk of Heart Failure With Preserved Versus Reduced Ejection Fraction.
Circulation. 2018;137:1290-1292.
PubMed

AUBDOOL AA, Argunhan F, Thakore P, Brain SD, et al
Response by Aubdool et al to Letters Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
Circulation. 2018;137:1201-1202.
PubMed

JIN-SHAN H, Xue-Bin L
Letter by Jin-shan and Xue-bin Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
Circulation. 2018;137:1200.
PubMed

TSUDA K
Letter by Tsuda Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
Circulation. 2018;137:1198-1199.
PubMed

RADHOLM K, Figtree G, Perkovic V, Solomon SD, et al
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.034222.
PubMed Abstract available

CHANG PP, Wruck LM, Shahar E, Rossi JS, et al
Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.
Circulation. 2018 Mar 8. pii: CIRCULATIONAHA.117.027551.
PubMed Abstract available

VIJAYAKUMAR S, Vaduganathan M, Butler J
Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.
Circulation. 2018;137:1060-1073.
PubMed Abstract available

February 2018

MORINE KJ, Qiao X, York S, Natov PS, et al
Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
Circulation. 2018 Feb 27. pii: CIRCULATIONAHA.117.031635.
PubMed Abstract available

KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of C
Circulation. 2018;137:989-991.
PubMed

JIN-SHAN H, Xue-Bin L
Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovas
Circulation. 2018;137:988.
PubMed

TAEGTMEYER H, Karlstaedt A
Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Card
Circulation. 2018;137:986-987.
PubMed

KOH KK
Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in
Circulation. 2018;137:984-985.
PubMed

TAMPAKI EC, Tampakis A, Pantos C
Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular O
Circulation. 2018;137:982-983.
PubMed

PINA IL, Zheng Q, She L, Szwed H, et al
Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
Circulation. 2018;137:771-780.
PubMed Abstract available

WENGER NK
Sauce for the Goose Versus Sauce for the Gander: Should Men and Women Play the Same Game But With Different Rules?
Circulation. 2018;137:791-793.
PubMed

ZHOU L, Miao K, Yin B, Li H, et al
The Cardioprotective Role of Myeloid-derived Suppressor Cells in Heart Failure.
Circulation. 2018 Feb 1. pii: CIRCULATIONAHA.117.030811.
PubMed Abstract available

January 2018

FLORIDO R, Kwak L, Lazo M, Nambi V, et al
Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study.
Circulation. 2018 Jan 31. pii: CIRCULATIONAHA.117.030226.
PubMed Abstract available

REDDY YNV, Obokata M, Gersh BJ, Borlaug BA, et al
High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.
Circulation. 2018;137:534-535.
PubMed

KUMBHANI DJ, Fonarow GC, Heidenreich PA, Schulte PJ, et al
Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure.
Circulation. 2018 Jan 29. pii: CIRCULATIONAHA.117.028077.
PubMed Abstract available

OBOKATA M, Borlaug BA
Response by Obokata and Borlaug to Letters Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
Circulation. 2018;137:416-417.
PubMed

CARBONE S, Canada JM, Abbate A
Letter by Carbone et al Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
Circulation. 2018;137:414-415.
PubMed

JIN-SHAN H, Xue-Bin L
Letter by Jin-shan and Xue-bin Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
Circulation. 2018;137:413.
PubMed

KOUTSAMPASOPOULOS K, Ouzouni C, Vogiatzis I
Letter by Koutsampasopoulos et al Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
Circulation. 2018;137:411-412.
PubMed

PANDEY A, Omar W, Ayers C, LaMonte M, et al
Sex and Race Differences in Lifetime Risk of Heart Failure with Preserved Ejection Fraction and Heart Failure with Reduced Ejection Fraction.
Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.031622.
PubMed Abstract available

AHMAD T, Jackson K, Rao VS, Tang WHW, et al
Worsening Renal Function in Acute Heart Failure Patients Undergoing Aggressive Diuresis is Not Associated with Tubular Injury.
Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.030112.
PubMed Abstract available

AIMO A, Januzzi JL Jr, Vergaro G, Ripoli A, et al
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
Circulation. 2018;137:286-297.
PubMed Abstract available

BORLAUG BA
Can Oxygen Transport Analysis Tell Us Why People With Heart Failure With Preserved Ejection Fraction Feel So Poorly?
Circulation. 2018;137:162-165.
PubMed

JOLLY SS, Gao P, Cairns JA, Yusuf S, et al
Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).
Circulation. 2018;137:206-209.
PubMed

NAMBI V, Deswal A, Ballantyne CM
Prevention of "Failure": Is It a Failure of Prevention?
Circulation. 2018;137:106-108.
PubMed

HOUSTIS NE, Eisman AS, Pappagianopoulos PP, Wooster L, et al
Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis.
Circulation. 2018;137:148-161.
PubMed Abstract available

HOWDEN EJ, Sarma S, Lawley JS, Opondo M, et al
Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications For Heart Failure Prevention.
Circulation. 2018 Jan 8. pii: CIRCULATIONAHA.117.030617.
PubMed Abstract available

GERSTEIN HC, Jung H, Ryden L, Diaz R, et al
Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention).
Circulation. 2018;137:88-90.
PubMed

STEHLIK J, Kobashigawa J, Hunt SA, Reichenspurner H, et al
Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-of-the-Art Review.
Circulation. 2018;137:71-87.
PubMed Abstract available

CHUGH SS
Disrupting the Approach to Sudden Cardiac Death: From Vulnerable Ejection Fraction to Vulnerable Patient.
Circulation. 2018;137:7-9.
PubMed

December 2017

FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
PubMed Abstract available

STIENEN S, Salah K, Moons AH, Bakx AL, et al
NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial.
Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.029882.
PubMed Abstract available

WU S, Lu Q, Wang Q, Ding Y, et al
Binding of FUN14 Domain Containing 1 With Inositol 1,4,5-Trisphosphate Receptor in Mitochondria-Associated Endoplasmic Reticulum Membranes Maintains Mitochondrial Dynamics and Function in Hearts in Vivo.
Circulation. 2017;136:2248-2266.
PubMed Abstract available

November 2017

DU J, Ma XL, Li Y, Chen B, et al
Response by Du et al to Letter Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling".
Circulation. 2017;136:2094-2095.
PubMed

LI Y, Liu B, Liang C
Letter by Li et al Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling".
Circulation. 2017;136:2092-2093.
PubMed

FELDMAN T, Mauri L, Kahwash R, Litwin S, et al
A Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): A Phase 2, Randomized, Sham-Controlled Trial.
Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.117.032094.
PubMed Abstract available

UDELL JA, Yuan Z, Rush T, Sicignano NM, et al
Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Co-Transporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study.
Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.031227.
PubMed Abstract available

Correction to: Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2017;136:e345.
PubMed

MEHRA MR, Sundareswaran KS, Uriel N
Response by Mehra et al to Letter Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure".
Circulation. 2017;136:1872-1873.
PubMed

MALTAIS S, Tchantchaleishvili V, Stulak JM
Letter by Maltais et al Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure".
Circulation. 2017;136:1870-1871.
PubMed

AL-KHATIB SM, Pokorney SD
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?
Circulation. 2017;136:1781-1783.
PubMed

October 2017

LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
Circulation. 2017;136:1643-1658.
PubMed Abstract available

MANN DL
High-Resolution Chromatin Mapping in Heart Failure: Some Answers, but More Questions.
Circulation. 2017;136:1626-1628.
PubMed

WOLSK E, Claggett B, Diaz R, Dickstein K, et al
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Circulation. 2017;136:1560-1562.
PubMed

PACKER M
Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure.
Circulation. 2017;136:1548-1559.
PubMed Abstract available

RAU CD, Vondriska TM
DNA Methylation and Human Heart Failure: Mechanisms or Prognostics.
Circulation. 2017;136:1545-1547.
PubMed

BUTLER J, Anker SD
The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?
Circulation. 2017;136:1459-1461.
PubMed

NUNEZ J, Bayes-Genis A, Zannad F, Rossignol P, et al
Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.030576.
PubMed Abstract available

KATZ SD
"Pumping Iron" to Improve Exercise Performance in Heart Failure: New Data and New Guidelines.
Circulation. 2017;136:1384-1386.
PubMed

CHO JH, Zhang R, Kilfoil PJ, Gallet R, et al
Delayed Repolarization Underlies Ventricular Arrhythmias in Rats with Heart Failure and Preserved Ejection Fraction.
Circulation. 2017 Oct 3. pii: CIRCULATIONAHA.117.028202.
PubMed Abstract available

September 2017

ROWIN EJ, Hausvater A, Link MS, Abt P, et al
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
PubMed Abstract available

PANDEY A, Berry JD
Physical Activity in Heart Failure With Preserved Ejection Fraction: Moving Toward a Newer Treatment Paradigm.
Circulation. 2017;136:993-995.
PubMed

ELMING MB, Nielsen JC, Haarbo J, Videbaek L, et al
Age and Outcomes of Primary Prevention Implantable Cardioverter Defibrillators in Patients with Non-Ischemic Systolic Heart Failure.
Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.028829.
PubMed Abstract available

WAAGSTEIN F, Rutherford JD
The Evolution of the Use of beta-Blockers to Treat Heart Failure: A Conversation With Finn Waagstein, MD.
Circulation. 2017;136:889-893.
PubMed Abstract available

August 2017

CHRISTIANSEN MN, Kober L, Andersson C
Response by Christiansen et al to Letters Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
Circulation. 2017;136:886-887.
PubMed

KAUL P, Ezekowitz JA, McAlister FA
Letter by Kaul et al Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
Circulation. 2017;136:884-885.
PubMed

GABET A, Juilliere Y, Olie V
Letter by Gabet et al Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
Circulation. 2017;136:883.
PubMed

SOLIMAN OI, Akin S, Muslem R, Boersma E, et al
Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices:The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk
Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030543.
PubMed Abstract available

MEDER B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, et al
Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and A Novel Class of Biomarkers for Heart Failure.
Circulation. 2017 Aug 24. pii: CIRCULATIONAHA.117.027355.
PubMed Abstract available

CHANG LL, DeVore AD, Granger BB, Eapen ZJ, et al
Leveraging Behavioral Economics to Improve Heart Failure Care and Outcomes.
Circulation. 2017;136:765-772.
PubMed Abstract available

ROSA-GARRIDO M, Chapski DJ, Schmitt AD, Kimball TH, et al
High Resolution Mapping of Chromatin Conformation in Cardiac Myocytes Reveals Structural Remodeling of the Epigenome in Heart Failure.
Circulation. 2017 Aug 11. pii: CIRCULATIONAHA.117.029430.
PubMed Abstract available

ELLINGSEN O, Halle M, Prescott E, Linke A, et al
Response by Ellingsen et al to Letters Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
Circulation. 2017;136:611-612.
PubMed

BIANCHI VE
Letter by Bianchi Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
Circulation. 2017;136:609-610.
PubMed

WISLOFF U, Lavie CJ, Rognmo O
Letter by Wisloff et al Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
Circulation. 2017;136:607-608.
PubMed

IELLAMO F, Volterrani M
Letter by Iellamo and Volterrani Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
Circulation. 2017;136:605-606.
PubMed

KUEHN BM
How Low Is Too Low With Salt in Heart Failure? Randomized Studies Needed to Resolve Concern.
Circulation. 2017;136:597-598.
PubMed

KALMAN JM, Sanders P, Rosso R, Calkins H, et al
Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
Circulation. 2017;136:490-499.
PubMed Abstract available

July 2017

OBOKATA M, Borlaug BA
Response by Obokata and Borlaug to Letter Regarding Article, "Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study".
Circulation. 2017;136:430-431.
PubMed

SMISETH OA, Nagueh SF
Letter by Smiseth and Nagueh et al Regarding Article, "Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study".
Circulation. 2017;136:428-429.
PubMed

MCALISTER FA, Youngson E, Kaul P
Health Resource Implications of Heart Failure Hospitalizations in Younger Patients Compared With Older Patients.
Circulation. 2017;136:424-427.
PubMed

KAPUR NK, Esposito ML, Bader Y, Morine KJ, et al
Mechanical Circulatory Support Devices for Acute Right Ventricular Failure.
Circulation. 2017;136:314-326.
PubMed Abstract available

VAN VELDHUISEN DJ, Ponikowski P, van der Meer P, Metra M, et al
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency.
Circulation. 2017 Jul 12. pii: CIRCULATIONAHA.117.027497.
PubMed Abstract available

GILSTRAP LG, DeFilippis EM, Stevenson LW
An Unintended Consequence of the 21st-Century Cures Act for Patients With Heart Failure.
Circulation. 2017;136:123-125.
PubMed

AHMAD FS, Chan C, Rosenman MB, Post WS, et al
Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
PubMed Abstract available

KITZMAN DW, Lam CSP
Obese Heart Failure With Preserved Ejection Fraction Phenotype: From Pariah to Central Player.
Circulation. 2017;136:20-23.
PubMed

June 2017

HEGDE S, Claggett B, Shah AM, Lewis EF, et al
Physical Activity and Prognosis in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
Circulation. 2017 Jun 21. pii: CIRCULATIONAHA.117.028002.
PubMed Abstract available

RUBIN GA, Grinspan LT, Ginns J
Of a Tortuous Nature: An Unusual Cause of Peripartum Congestive Heart Failure.
Circulation. 2017;135:2567-2571.
PubMed

TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
PubMed Abstract available

May 2017

PARIKH KS, Lippmann SJ, Greiner M, Heidenreich PA, et al
Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).
Circulation. 2017;135:2077-2080.
PubMed

DAVIS J
Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
Circulation. 2017;135:2058-2061.
PubMed

KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study.
Circulation. 2017 May 18. pii: CIRCULATIONAHA.117.029190.
PubMed Abstract available

April 2017

YANCY CW, Jessup M, Bozkurt B, Butler J, et al
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of
Circulation. 2017 Apr 28. pii: CIR.0000000000000509.
PubMed

AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
PubMed Abstract available

CHOW SL, Maisel AS, Anand I, Bozkurt B, et al
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2017 Apr 26. pii: CIR.0000000000000490.
PubMed Abstract available

BRESS AP, Kramer H, Khatib R, Beddhu S, et al
Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
Circulation. 2017;135:1617-1628.
PubMed Abstract available

VERMA A, Kalman JM, Callans DJ
Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
Circulation. 2017;135:1547-1563.
PubMed Abstract available

GORTER TM, Rienstra M, van Veldhuisen DJ
Measuring Pulmonary Artery Pressures in Heart Failure: A New Useful Diagnostic Tool?
Circulation. 2017;135:1518-1521.
PubMed

GORI M, Senni M, Metra M
High-Sensitive Cardiac Troponin for Prediction of Clinical Heart Failure: Are We Ready for Prime Time?
Circulation. 2017;135:1506-1508.
PubMed

PACKER M
Response by Packer to Letter Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective".
Circulation. 2017;135:e892-e893.
PubMed

BROWN PM, Ezekowitz JA
Letter by Brown and Ezekowitz Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective".
Circulation. 2017;135:e889-e891.
PubMed

URIEL N, Colombo PC, Cleveland JC, Long JW, et al
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
Circulation. 2017 Apr 6. pii: CIRCULATIONAHA.117.028303.
PubMed Abstract available

OBOKATA M, Reddy YN, Pislaru SV, Melenovsky V, et al
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction.
Circulation. 2017 Apr 5. pii: CIRCULATIONAHA.116.026807.
PubMed Abstract available

LAM CS, Solomon SD
Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction.
Circulation. 2017;135:1279-1280.
PubMed

March 2017

ROSAMOND WD, Johnson A
Trends in Heart Failure Incidence in the Community: A Gathering Storm.
Circulation. 2017;135:1224-1226.
PubMed

METHAWASIN M, Granzier H
Response by Methawasin and Granzier to Letter Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection F
Circulation. 2017;135:e681-e682.
PubMed

LEWIS GA, Miller CA
Letter by Lewis and Miller Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction".
Circulation. 2017;135:e679-e680.
PubMed

SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
PubMed Abstract available

FIDLER MM, Reulen RC, Henson K, Kelly J, et al
Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.
Circulation. 2017;135:951-963.
PubMed Abstract available

SUNDSTROM J, Bruze G, Ottosson J, Marcus C, et al
Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.
Circulation. 2017 Mar 3. pii: CIRCULATIONAHA.116.025629.
PubMed Abstract available

LI Y, Li Z, Zhang C, Li P, et al
Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
PubMed Abstract available

February 2017

KONSTAM MA, Abboud FM
Ejection Fraction: Misunderstood and Overrated (Changing the Paradigm in Categorizing Heart Failure).
Circulation. 2017;135:717-719.
PubMed

CHRISTIANSEN MN, Kober L, Weeke P, Vasan RS, et al
Age-specific Trends in Incidence, Mortality and Comorbidities of Heart Failure in Denmark 1995-2012.
Circulation. 2017 Feb 7. pii: CIRCULATIONAHA.116.025941.
PubMed Abstract available

TIBURCY M, Hudson JE, Balfanz P, Schlick SF, et al
Defined Engineered Human Myocardium with Advanced Maturation for Applications in Heart Failure Modelling and Repair.
Circulation. 2017 Feb 6. pii: CIRCULATIONAHA.116.024145.
PubMed Abstract available

SELIGER SL, Hong SN, Christenson RH, Kronmal R, et al
High Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.116.025505.
PubMed Abstract available

RAO MP, Al-Khatib SM, Pokorney S, She L, et al
Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
PubMed Abstract available

January 2017

SAIKI H, Petersen IA, Scott CG, Bailey KR, et al
Risk of Heart Failure with Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer.
Circulation. 2017 Jan 29. pii: CIRCULATIONAHA.116.025434.
PubMed Abstract available

PENG D, Zhang Y, Rosenthal DN, Palmon M, et al
Impact of Heart Transplantation on the Functional Status of U.S. Children with End-Stage Heart Failure. Analysis of Data from the Organ Procurement and Transplantation Network.
Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.115.016520.
PubMed Abstract available

ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
Circulation. 2017;135:400-402.
PubMed

NARAYAN HK, Finkelman BS, French B, Plappert T, et al
Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations with Ejection Fraction Decline, Recovery, and Heart Failure Symptoms over 3 Years of Followup.
Circulation. 2017 Jan 19. pii: CIRCULATIONAHA.116.023463.
PubMed Abstract available

HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failur
Circulation. 2017;135:e22-e23.
PubMed

DHRUVA SS, Redberg RF
Letter by Dhruva and Redberg Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Pr
Circulation. 2017;135:e20-e21.
PubMed

ELLINGSEN O, Halle M, Conraads VM, Stoylen A, et al
High Intensity Interval Training in Heart Failure Patients with Reduced Ejection Fraction.
Circulation. 2017 Jan 12. pii: CIRCULATIONAHA.116.022924.
PubMed Abstract available

SEIDEL T, Navankasattusas S, Ahmad AA, Diakos NA, et al
Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading.
Circulation. 2017 Jan 10. pii: CIRCULATIONAHA.116.024470.
PubMed Abstract available

KRISTENSEN SL, Mogensen UM, Jhund PS, Petrie MC, et al
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Tria
Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.024593.
PubMed Abstract available

December 2016

OBOKATA M, Kane GC, Reddy YN, Olson TP, et al
The Role of Diastolic Stress Testing in the Evaluation for HFpEF:A Simultaneous Invasive-Echocardiographic Study.
Circulation. 2016 Dec 30. pii: CIRCULATIONAHA.116.024822.
PubMed Abstract available

JOLLY SS, James SK, Dzavik V, Cairns JA, et al
Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
PubMed Abstract available

MARQUES FZ, Nelson EM, Chu PY, Horlock D, et al
High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice.
Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.024545.
PubMed Abstract available

ABU-TAHA IH, Heijman J, Hippe HJ, Wolf NM, et al
Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure.
Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.022852.
PubMed Abstract available

November 2016

NADRUZ W JR, Claggett BL, McMurray JJ, Packer M, et al
Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Pros
Circulation. 2016;134:1785-1787.
PubMed

SHAH AM, Claggett B, Loehr LR, Chang PP, et al
Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.023361.
PubMed Abstract available

MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
PubMed Abstract available

PACKER M
Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective.
Circulation. 2016;134:1664-1678.
PubMed Abstract available

GAGGIN HK, Liu Y, Lyass A, van Kimmenade RR, et al
Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.023052.
PubMed Abstract available

MEHRA MR, Lindenfeld J
Highlights of the Annual Scientific Meeting of the Heart Failure Society of America 2016.
Circulation. 2016;134:1505-1506.
PubMed

ZUHLKE L, Karthikeyan G, Engel ME, Rangarajan S, et al
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
Circulation. 2016;134:1456-1466.
PubMed Abstract available

LYNGBAKKEN MN, Skranes JB, de Lemos JA, Nygard S, et al
Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study.
Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023726.
PubMed Abstract available

WANG Q, Liu Y, Fu Q, Xu B, et al
Inhibiting Insulin-Mediated beta2AR Activation Prevents Diabetes-Associated Cardiac Dysfunction.
Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.022281.
PubMed Abstract available

MCKELLAR SH, Fang JC
An Age-Old Question: What Is Too Old for Coronary Artery Bypass Grafting in Heart Failure?
Circulation. 2016;134:1325-1327.
PubMed

AL-KHATIB SM, Friedman P, Ellenbogen KA
Defibrillators: Selecting the Right Device for the Right Patient.
Circulation. 2016;134:1390-1404.
PubMed Abstract available

October 2016

BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
PubMed

FILIPPOV AA, Del Nido PJ, Vasilyev NV
Management of Systemic Right Ventricular Failure in Patients With Congenitally Corrected Transposition of the Great Arteries.
Circulation. 2016;134:1293-1302.
PubMed Abstract available

FRIEDMAN DJ, Bao H, Spatz ES, Curtis JP, et al
Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report from the National Cardiovascular Data Registry.
Circulation. 2016 Oct 19. pii: CIRCULATIONAHA.116.022913.
PubMed Abstract available

LEWINTER MM, Zile MR
Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?
Circulation. 2016;134:1100-1104.
PubMed

METHAWASIN M, Strom JG, Slater RE, Fernandez V, et al
Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
Circulation. 2016;134:1085-1099.
PubMed Abstract available

Correction to: Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?
Circulation. 2016;134:e307.
PubMed

COWIE MR
Returning to Work: A Forgotten Aspect of Rehabilitation for Heart Failure.
Circulation. 2016;134:1010-1012.
PubMed

September 2016

Correction to: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart As
Circulation. 2016;134:e298.
PubMed

MELGARI D, Ng GA, Hancox JC
Letter by Melgari et al Regarding Article, "Ivabradine: Role in the Chronic Heart Failure Armamentarium".
Circulation. 2016;134:e296-7.
PubMed

CALVERT PA, Northridge DB, Malik IS, Shapiro L, et al
Percutaneous Device Closure of Paravalvular Leak: Combined Experience From the United Kingdom and Ireland.
Circulation. 2016;134:934-44.
PubMed Abstract available

Correction to: Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.
Circulation. 2016;134:e261.
PubMed

WIJESURENDRA RS, Liu A, Eichhorn C, Ariga R, et al
"Lone" Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persist Despite Successful Catheter Ablation.
Circulation. 2016 Sep 14. pii: CIRCULATIONAHA.116.022931.
PubMed Abstract available

August 2016

PACKER M
Heart Failure's Dark Secret: Does Anyone Really Care About Optimal Medical Therapy?
Circulation. 2016;134:629-31.
PubMed

July 2016

TAEGTMEYER H
Failing Heart and Starving Brain: Ketone Bodies to the Rescue.
Circulation. 2016;134:265-6.
PubMed

RAJAPAKSE NW, Kuruppu S, Ian Smith A
Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
Circulation. 2016;134:e9-e10.
PubMed

HUBERS SA, Brown NJ
Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
Circulation. 2016;134:e11-2.
PubMed

HE VY, Condon JR, Ralph AP, Zhao Y, et al
Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
Circulation. 2016;134:222-32.
PubMed Abstract available

May 2016

MCMURRAY JJ
Disease Management Programs in Cardiology: Extending the Success in Failure.
Circulation. 2016;133:1836-7.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: